Paula Soteropoulos's Net Worth
$11.7 Million
Who is Paula Soteropoulos?
Paula Soteropoulos has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include uniQure N.V., Rallybio Corp, AKCEA THERAPEUTICS, INC., and Dianthus Therapeutics, Inc. /DE/.
SEC CIK
Paula Soteropoulos's CIK is 0001692444
Past Insider Trading and Trends
2019 was Paula Soteropoulos's most active year for acquiring shares with 11 total transactions. Paula Soteropoulos's most active month to acquire stocks was the month of December. 2019 was Paula Soteropoulos's most active year for disposing of shares, totalling 17 transactions. Paula Soteropoulos's most active month to dispose stocks was the month of November. 2019 saw Paula Soteropoulos paying a total of $14,874,114.99 for 2,420,559 shares, this is the most they've acquired in one year. In 2019 Paula Soteropoulos cashed out on 3,560,711 shares for a total of $25,567,851.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
uniQure N.V. (QURE) Snapshot price: $5.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.90% | -2.22K |
$5.14 | -$11,410.80 | 20.2K |
Jun 13
| |||
Form 4
| +40.16% | 6.42K |
$18.99 | -$43,202.25 | 22.42K |
Jun 13 - Jun 16
| |||
Form 4
| -2.34% | -384.00 |
$19.97 | -$7,668.48 | 16K |
Feb 27
| |||
Form 4
|
—
|
0
|
$13.98 | -$103,320.00 | 16.38K |
Scheduled
|
Jan 18
| ||
Form 4
|
—
|
0
|
$14.41 | -$159,384.00 | 16.38K |
Scheduled
|
Dec 13 - Dec 14
| ||
Form 4
|
—
|
0
|
$25.38 | -$157,356.00 | 16.38K |
Scheduled
|
Nov 29
| ||
Form 4
| +124.35% | 9.08K |
—
|
—
| 16.38K |
Jun 15
| |||
Form 4
| -7.55% | -596.00 |
$16.87 | -$10,054.52 | 7.3K |
Feb 28
| |||
Form 4
| +24.10% | 1.53K |
—
|
—
| 7.9K |
Feb 24
| |||
Form 4
| -7.34% | -504.00 |
$37.60 | -$18,950.40 | 6.36K |
Mar 2
| |||
Form 4
| +53.10% | 2.38K |
—
|
—
| 6.87K |
Feb 25
| |||
Form 4
| +85.14% | 2.06K |
—
|
—
| 4.49K |
Feb 27
| |||
Form 4
| -46.69% | -2.12K |
$60.95 | -$129,331.66 | 2.42K |
Scheduled
|
Feb 5
| ||
Form 4
| -15.08% | -807.00 |
$62.19 | -$50,187.33 | 4.54K |
Jan 28
| |||
Form 4
| -35.92% | -3.00K |
$72.18 | -$216,540.00 | 5.35K |
Scheduled
|
Jan 7
| ||
Form 4
|
—
|
0
|
$37.94 | -$130,260.00 | 8.35K |
Scheduled
|
Dec 13
| ||
Form 4
| -58.10% | -11.58K |
$64.96 | -$752,349.98 | 8.35K |
Scheduled
|
Dec 6 - Dec 9
| ||
Form 4
| -5.72% | -1.21K |
$31.32 | -$37,897.20 | 19.93K |
Jan 28
| |||
Form 4
| +18.03% | 3.23K |
—
|
—
| 21.14K |
Jan 25
| |||
Form 4
| -13.84% | -2.88K |
$18.53 | -$53,329.34 | 17.91K |
Jan 29
| |||
Form 4
| +29.95% | 4.79K |
—
|
—
| 20.79K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rallybio Corp (RLYB) Snapshot price: $1.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AKCEA THERAPEUTICS, INC. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 678.15K |
$11.85 | -$8,486,713.73 | 678.15K |
Sep 26
| |||
Form 4
|
—
|
0
|
$19.30 | -$814,800.52 |
0
|
Scheduled
|
Apr 5 - Apr 8
| ||
Form 4
|
—
|
0
|
$19.31 | -$471,714.89 |
0
|
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dianthus Therapeutics, Inc. /DE/ (DNTH) Snapshot price: $26.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||